1 unknown. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow raltitrexed: new trials by email Literature Review of raltitrexed trials Research Report on raltitrexed
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Regorafenib Plus Raltitrexed as Third-line Treatment in Advanced Colorectal Cancer Patients Regorafenib, Raltitrexed - Regorafenib, Raltitrexed | Phase 1 / Phase 2 | Unknown | China Medical University, China | 50 | 2022-07-01 | 2022-06-29 |
China Medical University, China (1)
Yunpeng Liu, PhD (1)